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Background:
One third of the world's population is considered to be infected with Mycobacterium tuberculosis, which leads to nearly 9.4 million new patients and 3 million deaths every year [1]. Multi-drug-resistant strains of this pathogen, emerging in association with HIV, have added a frightening dimension to the problem [2] . Outbreaks of extensively drug-resistant (XDR) tuberculosis have also been an increasing threat in certain regions around the world [3] . As M. tb H37Rv is virulent and susceptible to most of the antitubercular drugs used so far, H37Ra which is an avirulent strain 
Database Architecture & Design:
Standalone BLAST program from NCBI was also downloaded and configured for local system. The proteome sequence were formatted using formatdb program of standalone BLAST, followed by pairwise comparison (Local BLAST) among each strain using blastall program of standalone BLAST taking whole proteome at a time. Mycobacterium tuberculosis Proteome Comparison Database (MTB-PCDB) was developed using Microsoft SQL Server as the back end. The output of the BLAST result was then parsed and stored in MS SQL relational database tables using in-house developed PERL code. While parsing BLAST output results, percentage identities, positivities, number of gaps, identical residues, bits, bits score, e-value, query length, subject length, query sequence, subject sequence, consensus sequence etc of the first hit obtained were taken into consideration for each protein comparison.
Data Access:
The interfaces of MTB-PCDB are designed in a manner to help users in easy navigation and retrieval of information from database for analysis. 
Caveats:
MTB-PCDB does not include comparison of all the strains of M. tb as they are not completely sequenced.
Future Developments:
As and when in future, new TB strains are sequenced and available in public databases, we shall attempt to update MTB-PCDB including newly proteome comparison data. We would continue working on analyzing and correlating the proteomic variation among different strains with their drug resistance, virulence and pathogenic properties.
